跳至主要内容
临床试验/NCT05158751
NCT05158751尚未招募不适用

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry

Kansas City Heart Rhythm Research Foundation1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Identify the underlying myocarditis in patients presenting with PVCs with or without reduced LVEF

研究概览

简要总结

To assess potential link between unrecognized myocardial inflammation (myocarditis) and premature ventricular contractions (PVCs) associated with and without reduced Left ventricular ejection fraction (LVEF) through comprehensive diagnostic work up.

详细描述

Hypothesized that occult inflammation is clinically under-recognized in patients with symptomatic PVCs with and without Left ventricular (LV) dysfunction and can be a potential link between the 2 conditions. Aimed to evaluate the incidence of underlying inflammation using the Positron emission tomography (PET) scan in patients presenting with symptomatic PVCs enrolled retrospectively in the MAVERIC registry.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients > 18 years of age with mono-morphic or polymorphic PVC burden of ≥5000 in 24 hours.
  • Non-sustained VT was defined as ≥3 more consecutive beats lasting <30 seconds

排除标准

  • History of myocardial infarction,
  • Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or CT angiography,
  • History of revascularization,
  • Significant symptomatic atrial arrhythmias associated with LV dysfunction,
  • Severe valvular disease,
  • Cardiomyopathy attributed to toxins such as alcohol and illicit drugs,
  • History of cardiac arrest,
  • History of channelopathies or inherited arrhythmias.

结局指标

主要结局

Identify the underlying myocarditis in patients presenting with PVCs with or without reduced LVEF

时间窗: Retrospective Collection between dates January 2014-January 2023

To identify the underlying myocarditis in patients presenting with PVCs with or without reduced LVEF through laboratory testing, FDG-PET(18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose - positron emission tomography) scan, Cardiac Magnetic Resonance imaging and/or Endomyocardial biopsy.

次要结局

  • Ascertain whether immunosuppressive therapy (IST) affords short term and long term improvement of LVEF and clinical outcomes(Retrospective Collection between dates January 2014-January 2023)

研究者

发起方
Kansas City Heart Rhythm Research Foundation
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验